Ergomed plc and Permira Advisers LLP, are pleased to announce the completion of the acquisition of Ergomed by funds advised by Permira for £703.1 million.
Ergomed is an England-based clinical research company that provides services such as case processing and pharmacovigilance for the pharmaceutical industry.